Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(67%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Completed(1)

Detailed Status

Recruiting2
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
2
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

completed133%
recruiting267%

Recent Activity

2 active trials
Showing 3 of 3
recruitingnot_applicable

Sequential and Comparative Evaluation of Pain Treatment Effectiveness Response

NCT04142177
recruitingnot_applicable

Tailored Exercise to Reduce Aromatase Inhibitor Associated Musculoskeletal Symptoms

NCT07448558
completednot_applicable

Tailored Exercise Interventions to Reduce Fatigue in Cancer Survivors

NCT03049384

Clinical Trials (3)

Showing 3 of 3 trials
NCT04142177Not Applicable

Sequential and Comparative Evaluation of Pain Treatment Effectiveness Response

Recruiting
NCT07448558Not Applicable

Tailored Exercise to Reduce Aromatase Inhibitor Associated Musculoskeletal Symptoms

Recruiting
NCT03049384Not Applicable

Tailored Exercise Interventions to Reduce Fatigue in Cancer Survivors

Completed

All 3 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
3